| Identification | Back Directory | [Name]
1,2-Pyrrolidinedicarboxylic acid, 4-[(3-chloro-7-Methoxy-2-quinoxalinyl)oxy]-, 1-(1,1-diMethylethyl) 2-Methyl ester,(2S,4R)- | [CAS]
1206524-79-9 | [Synonyms]
Grazoprevir Intermediate 2
(2S,4R)-1-tert-butyl 2-Methyl 4-((3-chloro-7-Methoxyquinoxalin-2-yl)oxy)pyrrolidine-1,2-dicarboxylate
1-(tert-Butyl) 2-methyl (2S,4R)-4-((3-chloro-7-methoxyquinoxalin-2-yl)oxy)pyrrolidine-1,2-dicarboxylate
(2S,4R)-4-[(3-Chloro-7-methoxy-2-quinoxalinyl)oxy]-,1-(1,1-dimethylethyl),- 1,2-Pyrrolidinedicarboxylic Acid 2-Methyl Ester
1,2-Pyrrolidinedicarboxylic acid, 4-[(3-chloro-7-Methoxy-2-quinoxalinyl)oxy]-, 1-(1,1-diMethylethyl) 2-Methyl ester,(2S,4R)- | [Molecular Formula]
C20H24ClN3O6 | [MOL File]
1206524-79-9.mol | [Molecular Weight]
437.87 |
| Hazard Information | Back Directory | [Uses]
(2S,4R)-4-[(3-Chloro-7-methoxy-2-quinoxalinyl)oxy]-,1-(1,1-dimethylethyl),- 1,2-Pyrrolidinedicarboxylic Acid 2-Methyl Ester acts as a reagent in the discovery of MK-5172 (M424985), a macrocyclic analog as an antiviral protease inhibitor. Reagent in the discovery of quinoxaline-based metathesis catalysts from the synthesis of Grazoprevir. It is a COVID19-related research product. |
|
|